8:30 AM8:37 AMESTIMATING STRENGTH AND ENDURANCE EXERCISE PRESCRIPTION IN PATIENTS WITH OBESITY IN A CARDIAC REHABILITATION PROGRAMMaria del Mar Amaya Campos Add to my agenda
8:37 AM8:45 AMUSING A COMBINATION OF DIET AND MEDICAL MEAL REPLACEMENT TO REDUCE BODY FAT PERCENTAGE IN LOW METABOLIC RATE OVERWEIGHT INDIVIDUALTerry Ho Yan TINGMINT DIETITIAN CLINIC Add to my agenda
8:45 AM8:52 AMPOSTPRANDIAL MULTI-OMICS REVEALS DIET- AND MICROBIOTA-DRIVEN METABOLIC MEDIATORS OF VASCULAR DYSFUNCTION IN OBESITYHechun LiuNanjing Medical University Add to my agenda
8:52 AM9:00 AMPRE-PREGNANCY BODY MASS INDEX AND GESTATIONAL DIABETES AS DETERMINANTS OF LONG-TERM METABOLIC SYNDROME RISK: A DECISION-MAKING ALGORITHMClara Marcuello FoncillasNESTLÉ - Hosp. Clínico San Carlos Add to my agenda
9:00 AM9:07 AMEFFECT OF BRANCHED-CHAIN AMINO ACID SUPPLEMENTATION ON LEAN MASS PRESERVATION IN OBESE PATIENTS TREATED WITH TIRZEPATIDE: A 4-MONTH GCP OBSERVATIONAL STUDYDaniele FumelliAST Ancona – Ospedale Carlo Urbani di Jesi Add to my agenda
9:07 AM9:15 AMCLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IS ASSOCIATED WITH METABOLIC SYNDROME AND DISPLAYS GENE-SPECIFIC PROTEOMIC SIGNATURES: A CROSS-SECTIONAL STUDY OF 325,107 UK BIOBANK PARTICIPANTSNaifei ChenThe First Hospital of Jilin University Add to my agenda
9:15 AM9:22 AMASSOCIATION OF SUBSTITUTING MEAT WITH PLANT-SOURCE FOODS AND TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE OBSERVATIONAL STUDIESEva KIESSWETTERInstitute for Evidence in Medicine, Medical Center - University of Freiburg/Medical Faculty - University of Freiburg Add to my agenda
9:22 AM9:30 AMBEYOND CALORIES: AN AI-POWERED REAL-WORLD STUDY OF MACRO- AND MICRONUTRIENT INTAKE IN GLP-1 RECEPTOR AGONIST USERS COMPARED TO NON-USERSValentina VINELLISan Raffaele Hospital Add to my agenda
9:30 AM9:37 AMNEUROMODULATION METHODOLOGIES TO TREAT OBESITY AND TYPE 2 DIABETES: NAIROBI STUDYCarlos HERNÁNDEZ MARTÍNEZCarloSportNutritionTiziana MONTALCINIuniversity of Catanzaro Add to my agenda
9:37 AM9:45 AMOSTEOPOROSIS IN TYPE 2 DIABETES.Asylkan MOLDOBAEVAInternational Higher School of MedicineSimona RambousekNestle Research Add to my agenda